Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study

Armando Santoro, Lorenza Rimassa, Ivan Borbath, Bruno Daniele, Stefania Salvagni, Jean Luc Van Laethem, Hans Van Vlierberghe, Jörg Trojan, Frank T Kolligs, Alan Weiss, Steven Miles, Antonio Gasbarrini, Monica Lencioni, Luca Cicalese, Morris Sherman, Cesare Gridelli, Peter Buggisch, Guido Gerken, Roland M Schmid, Corrado BoniNicola Personeni, Ziad Hassoun, Giovanni Abbadessa, Brian Schwartz, Reinhard Von Roemeling, Maria E Lamar, Yinpu Chen, Camillo Porta

Risultato della ricerca: Contributo in rivistaArticolo in rivista

436 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study'. Insieme formano una fingerprint unica.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science